Annual Net Income
-$53.84 M
-$3.70 M-7.38%
31 December 2023
Summary:
Silence Therapeutics annual net profit is currently -$53.84 million, with the most recent change of -$3.70 million (-7.38%) on 31 December 2023. During the last 3 years, it has fallen by -$12.07 million (-28.88%). SLN annual net income is now -3802.73% below its all-time high of -$1.38 million, reached on 31 December 1995.SLN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$35.15 M
-$15.51 M-79.02%
01 September 2024
Summary:
Silence Therapeutics quarterly net profit is currently -$35.15 million, with the most recent change of -$15.51 million (-79.02%) on 01 September 2024. Over the past year, it has dropped by -$24.70 million (-236.46%). SLN quarterly net income is now -1377.15% below its all-time high of -$2.38 million, reached on 31 March 2024.SLN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$75.06 M
-$24.70 M-49.05%
01 September 2024
Summary:
Silence Therapeutics TTM net profit is currently -$75.06 million, with the most recent change of -$24.70 million (-49.05%) on 01 September 2024. Over the past year, it has dropped by -$23.01 million (-44.21%). SLN TTM net income is now -539.86% below its all-time high of -$11.73 million, reached on 30 September 2020.SLN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.4% | -236.5% | -44.2% |
| 3 y3 years | -28.9% | -156.8% | -29.5% |
| 5 y5 years | -119.2% | - | - |
SLN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.9% | +0.7% | -1377.2% | at low | -71.6% | at low |
| 5 y | 5 years | -119.2% | +0.7% | -1377.2% | at low | -539.9% | at low |
| alltime | all time | -3802.7% | +0.7% | -1377.2% | at low | -539.9% | at low |
Silence Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$35.15 M(+79.0%) | -$75.06 M(+49.1%) |
| June 2024 | - | -$19.63 M(+725.1%) | -$50.36 M(+15.1%) |
| Mar 2024 | - | -$2.38 M(-86.7%) | -$43.74 M(-18.6%) |
| Dec 2023 | -$53.84 M(+7.4%) | -$17.90 M(+71.3%) | -$53.77 M(+3.3%) |
| Sept 2023 | - | -$10.45 M(-19.8%) | -$52.05 M(+4.2%) |
| June 2023 | - | -$13.02 M(+5.0%) | -$49.96 M(-3.8%) |
| Mar 2023 | - | -$12.40 M(-23.4%) | -$51.96 M(+4.2%) |
| Dec 2022 | -$50.14 M(-7.5%) | -$16.18 M(+93.6%) | -$49.86 M(+7.5%) |
| Sept 2022 | - | -$8.36 M(-44.3%) | -$46.40 M(-10.3%) |
| June 2022 | - | -$15.01 M(+45.6%) | -$51.73 M(-2.3%) |
| Mar 2022 | - | -$10.31 M(-18.9%) | -$52.97 M(-2.4%) |
| Dec 2021 | -$54.22 M(+29.8%) | -$12.72 M(-7.1%) | -$54.27 M(-6.4%) |
| Sept 2021 | - | -$13.69 M(-15.8%) | -$57.96 M(+3.5%) |
| June 2021 | - | -$16.25 M(+40.0%) | -$56.01 M(+40.9%) |
| Mar 2021 | - | -$11.61 M(-29.3%) | -$39.75 M(+41.2%) |
| Dec 2020 | -$41.77 M(+67.1%) | -$16.41 M(+39.9%) | -$28.14 M(+139.9%) |
| Sept 2020 | - | -$11.73 M | -$11.73 M |
| Dec 2019 | -$25.00 M(+1.8%) | - | - |
| Dec 2018 | -$24.56 M(+1075.9%) | - | - |
| Dec 2017 | -$2.09 M(-81.7%) | - | - |
| Dec 2016 | -$11.44 M(+12.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$10.16 M(-44.4%) | - | - |
| Dec 2014 | -$18.28 M(+29.8%) | - | - |
| Dec 2013 | -$14.08 M(-66.2%) | - | - |
| Dec 2012 | -$41.65 M(+352.7%) | - | - |
| Dec 2011 | -$9.20 M(-32.2%) | - | - |
| Dec 2010 | -$13.56 M(+15.9%) | - | - |
| Dec 2009 | -$11.70 M(-14.9%) | - | - |
| Dec 2008 | -$13.75 M(+34.5%) | - | - |
| Dec 2007 | -$10.22 M(+44.9%) | - | - |
| Dec 2006 | -$7.05 M(+8.1%) | - | - |
| Dec 2005 | -$6.52 M(+20.4%) | - | - |
| Dec 2004 | -$5.42 M(+45.3%) | - | - |
| Dec 2003 | -$3.73 M(+67.3%) | - | - |
| Dec 2002 | -$2.23 M(-29.5%) | - | - |
| Dec 2001 | -$3.16 M(+7.3%) | - | - |
| Dec 2000 | -$2.95 M(-14.9%) | - | - |
| Dec 1999 | -$3.46 M(+32.3%) | - | - |
| Dec 1998 | -$2.62 M(-9.3%) | - | - |
| Dec 1997 | -$2.88 M(+91.4%) | - | - |
| Dec 1996 | -$1.51 M(+9.3%) | - | - |
| Dec 1995 | -$1.38 M | - | - |
FAQ
- What is Silence Therapeutics annual net profit?
- What is the all time high annual net income for Silence Therapeutics?
- What is Silence Therapeutics annual net income year-on-year change?
- What is Silence Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Silence Therapeutics?
- What is Silence Therapeutics quarterly net income year-on-year change?
- What is Silence Therapeutics TTM net profit?
- What is the all time high TTM net income for Silence Therapeutics?
- What is Silence Therapeutics TTM net income year-on-year change?
What is Silence Therapeutics annual net profit?
The current annual net income of SLN is -$53.84 M
What is the all time high annual net income for Silence Therapeutics?
Silence Therapeutics all-time high annual net profit is -$1.38 M
What is Silence Therapeutics annual net income year-on-year change?
Over the past year, SLN annual net profit has changed by -$3.70 M (-7.38%)
What is Silence Therapeutics quarterly net profit?
The current quarterly net income of SLN is -$35.15 M
What is the all time high quarterly net income for Silence Therapeutics?
Silence Therapeutics all-time high quarterly net profit is -$2.38 M
What is Silence Therapeutics quarterly net income year-on-year change?
Over the past year, SLN quarterly net profit has changed by -$24.70 M (-236.46%)
What is Silence Therapeutics TTM net profit?
The current TTM net income of SLN is -$75.06 M
What is the all time high TTM net income for Silence Therapeutics?
Silence Therapeutics all-time high TTM net profit is -$11.73 M
What is Silence Therapeutics TTM net income year-on-year change?
Over the past year, SLN TTM net profit has changed by -$23.01 M (-44.21%)